SMN2 and proximal spinal muscular atrophy: This notion is partly supported by our previous study in severe-SMA mice rescued by therapeutic ASO-10-27: high levels of correction of SMN2 splicing are not persistently required, at least in the liver, for long-term survival (Hua et al, 2011).